نتایج جستجو برای: botulinum neurotoxin type e bonte

تعداد نتایج: 2292107  

2017
Michael W. Peck Theresa J. Smith Fabrizio Anniballi John W. Austin Luca Bano Marite Bradshaw Paula Cuervo Luisa W. Cheng Yagmur Derman Brigitte G. Dorner Audrey Fisher Karen K. Hill Suzanne R. Kalb Hannu Korkeala Miia Lindström Florigio Lista Carolina Lúquez Christelle Mazuet Marco Pirazzini Michel R. Popoff Ornella Rossetto Andreas Rummel Dorothea Sesardic Bal Ram Singh Sandra C. Stringer

Botulinum neurotoxins are diverse proteins. They are currently represented by at least seven serotypes and more than 40 subtypes. New clostridial strains that produce novel neurotoxin variants are being identified with increasing frequency, which presents challenges when organizing the nomenclature surrounding these neurotoxins. Worldwide, researchers are faced with the possibility that toxins ...

Journal: :Infection and immunity 1997
N Kiyatkin A B Maksymowych L L Simpson

A gene encoding the full-size botulinum neurotoxin serotype C was reconstructed in vector pQE-30 and expressed at high levels in Escherichia coli. Three amino acid mutations (H229-->G, E230-->T, and H233-->N) were generated in the zinc-binding motif, resulting in complete detoxification of the modified recombinant holotoxin. The PCR-amplified wild-type light chain of botulinum neurotoxin seroty...

2012
Harald Hefter Christian Hartmann Ulrike Kahlen Marek Moll Hans Bigalke

OBJECTIVES In long-term botulinum neurotoxin treatment, loss of therapeutic efficacy may occur due to neutralising antibody formation. Preliminary results with incobotulinumtoxinA, a preparation free of complexing/accessory proteins, have indicated a low antigenicity. We hypothesised that continuous treatment with this botulinum neurotoxin preparation would not result in an increase in neutrali...

Firouz Ebrahimi, Mohammad Ali Arefpour Torabi, Mohammad Ebrahim Minaei, Mosayeb Rostamian, Nader Sheibani, Seyed Jafar Mousavy, Seyyed Abolghasem Ghadami,

Background: Recently, botulinum neurotoxin (BoNT)-derived recombinant proteins have been suggested as potential botulism vaccines. Here, with concentrating on BoNT type E (BoNT/E), we studied two of these binding domain-based recombinant proteins: a multivalent chimer protein, which is composed of BoNT serotypes A, B and E binding subdomains, and a monovalent recombinant protein, which contains...

Journal: :iranian journal of toxicology 0
rahim nejadrahim department of infectious diseases & dermatology, urmia university of medical sciences, urmia, iran. mohammad delirrad department of forensic medicine & toxicology, food & beverages safety research center, urmia university of medical sciences, urmia, iran.

background: foodborne botulism (fbb) is a rare paralyzing disease caused by ingestion of foods contaminated with botulinum neurotoxin (bont). it is still a health concern in many countries. this study aimed to investigate the epidemiology of fbb in west azerbaijan province, iran. methods: botulism surveillance data of the health deputy of urmia medical sciences university, northwestern iran was...

Journal: :Critical reviews in microbiology 2005
H D Shukla S K Sharma

Clostridium botulinum, a Gram-positive, anaerobic spore-forming bacteria, is distinguished by its significant clinical applications as well as its potential to be used as bioterror agent. Growing cells secrete botulinum neurotoxin (BoNT), the most poisonous of all known poisons. While BoNT is the causative agent of deadly neuroparalytic botulism, it also serves as a remarkably effective treatme...

2015
Alison C. Savage Nicholas Buckley Jennifer Halliwell Christopher Gwenin Xiaohua He

Botulinum neurotoxin is one of the deadliest biological toxins known to mankind and is able to cause the debilitating disease botulism. The rapid detection of the different serotypes of botulinum neurotoxin is essential for both diagnosis of botulism and identifying the presence of toxin in potential cases of terrorism and food contamination. The modes of action of botulinum neurotoxins are wel...

2010
Petr Čapek Tobin J. Dickerson

Sensitive and rapid detection of botulinum neurotoxins (BoNTs), the most poisonous substances known to date, is essential for studies of medical applications of BoNTs and detection of poisoned food, as well as for response to potential bioterrorist threats. Currently, the most common method of BoNT detection is the mouse bioassay. While this assay is sensitive, it is slow, quite expensive, has ...

Journal: :Clinical and vaccine immunology : CVI 2008
Yun-Zhou Yu Na Li Rui-Lin Wang Heng-Qi Zhu Shuang Wang Wei-Yuan Yu Zhi-Wei Sun

A new gene encoding the Hc domain of Clostridium botulinum neurotoxin serotype F (FHc) was designed and completely synthesized with oligonucleotides. A soluble recombinant Hc of C. botulinum neurotoxin serotype F was highly expressed in Escherichia coli with this synthetic FHc gene. Subsequently, the purified FHc was used to vaccinate mice and evaluate their survival against challenge with acti...

2010
Jürgen Frevert

BACKGROUND Botulinum neurotoxin type A (BoNT/A) is the active substance in preparations used for the highly effective treatment of neurologic disorders such as cervical dystonia, blepharospasm, or spasticity, as well as other indications such as axillary and palmar hyperhidrosis, and urologic disorders. OBJECTIVE To determine the amount of BoNT/A protein present in pharmaceutical preparations...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید